Span Divergent Ltd-$

BSE: 524727

13

total announcements

524727.BO · 15 min delayed

BSEBoard MeetingResults30 Oct 2026

Span Divergent Ltd-$

Span Divergent Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve 1. To consider and approve the unaudited Standalone and consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2026 2. Other items of agenda

Span Divergent Ltd has informed BSE that a Board Meeting is scheduled on November 5, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026.

Read more →📎 1 attachment
BSEAGM/EGM28 Sept 2026

Span Divergent Ltd-$

Span Divergent Limited-Summary of Proceedings of the Annual General Meeting held on September 28, 2026

Span Divergent Ltd held its 46th Annual General Meeting on September 28, 2026, through video conferencing. The meeting was attended by the Chairman, Managing Director, CFO, Company Secretary, Statutory Auditor, and Secretarial Auditor. The agenda items included adopting audited financial statements, appointing a director, and approving related party transactions.

Read more →📎 1 attachment
BSEResultResults11 Aug 2026

Span Divergent Ltd-$

Span Divergent Limited-Financial Results for the quarter end June 30, 2026

Span Divergent Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, showing a net loss of Rs. 4.22 crores and a basic earnings per share of Rs. 0.06. The company has also provided details of its subsidiaries' financial performance, including accumulated losses and impairment of investments.

Read more →📎 1 attachment
BSEBoard MeetingResults11 Aug 2026

Span Divergent Ltd-$

Span Divergent Limited Outcome of Board Meeting held on August 11, 2026

Span Divergent Ltd. has announced its unaudited integrated financial results for the first quarter and three months ended June 30, 2026, with a net profit of Rs. 3.55 lakhs and a total income of Rs. 47.91 lakhs. The company has also provided details on its subsidiaries, including Aranya Consulting and Biotech LLP and Biospan Scientific LLP, which have accumulated losses. The financial results have been prepared on a going concern basis, with the management confident that the companies will achieve profitable operations in the short term.

Read more →📎 1 attachment